Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer - A Pivotal Study



Status:Completed
Conditions:Breast Cancer, Cancer
Therapuetic Areas:Oncology
Healthy:No
Age Range:18 - Any
Updated:10/18/2018
Start Date:April 6, 2018
End Date:August 31, 2018

Use our guide to learn which trials are right for you!

A Multi-Reader Multi-Case Controlled Clinical Trial to Evaluate the Comparative Accuracy of the Fujifilm DBT Plus S-View Versus FFDM Alone in the Detection of Breast Cancer - A Pivotal Study

The purpose of the pivotal reader study is to assess the comparative accuracy of Fujifilm DBT
plus S-View versus FFDM in the detection of breast cancer.

This clinical research is a retrospective, pivotal, multi-reader, multi-case (MRMC) study
with an enriched sample of 300 breast screening or diagnostic cases which were selected from
the library of mammograms collected under Fujifilm protocol FMSU2013-004A (all subjects
previously provided written informed consent agreeing their image data and supporting
documentation could be used for future research and investigations). Approximately 18
qualified radiologists will independently perform two reads on all (approximately 300) cases.
Each reader will read each case both as a FFDM read, and a DBT plus S-View read on the ASPIRE
Bellus II workstation.

As its primary endpoint, this study is designed to evaluate whether the area under the
receiver operating characteristic (ROC) curve (AUC) based on probability of malignancy (POM)
scores and requiring correct lesion localization is statistically non-inferior for DBT plus
S-View versus FFDM.

Inclusion Criteria:

- •Female subjects participating in FMSU2013-004A protocol with known clinical status

Exclusion Criteria:

- •Female subjects that did not have known clinical status in FMSU2013-004A
We found this trial at
1
site
98 East Avenue
Norwalk, Connecticut 06851
?
mi
from
Norwalk, CT
Click here to add this to my saved trials